Hospital Acquired Infections Testing Kits Market Outlook Signals Expansion To $7.19 Billion Through 2030

The Business Research Company

The Business Research Company's Hospital Acquired Infections Testing Kits Market Outlook Signals Expansion To $7.19 Billion Through 2030

LONDON, GREATER LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ -- "The market for hospital-acquired infections testing kits has seen significant growth lately, reflecting the critical role these kits play in healthcare settings. With increasing awareness of infection control and advancements in diagnostic technology, this sector is positioned for continued expansion. Let’s explore the market’s size, key growth factors, regional trends, and the dynamics shaping its future.

Hospital Acquired Infections Testing Kits Market Size and Growth Outlook
The hospital acquired infections testing kits market has experienced substantial growth and is projected to expand further. From a market size of $4.79 billion in 2025, it is expected to rise to $5.19 billion in 2026, growing at a compound annual growth rate (CAGR) of 8.5%. This historic growth has been driven by enhanced infection surveillance programs in hospitals, the increasing prevalence of antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, stricter infection control protocols, and the broader availability of molecular diagnostic tools. Looking ahead, the market is forecasted to reach $7.2 billion by 2030, maintaining the same CAGR of 8.5%. This anticipated growth will be supported by a greater emphasis on early infection detection, increased investments in hospital safety infrastructure, wider adoption of rapid testing methods, rising demand for automated diagnostic workflows, and advancements in molecular diagnostics technology. Key trends shaping the market include the growing use of rapid diagnostic test kits, expanded molecular testing applications for hospital-acquired infections (HAIs), integration of automated diagnostic instruments, expansion of point-of-care testing, and a stronger focus on detecting multiple pathogens simultaneously.

Download a free sample of the hospital acquired infections testing kits market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Understanding Hospital Acquired Infections Testing Kits and Their Applications
Hospital-acquired infection testing kits are essential tools designed to detect infections contracted within healthcare facilities. They target pathogens commonly linked to such infections, including vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and Clostridium difficile. These kits help healthcare providers identify infections promptly to prevent their spread and improve patient outcomes.

Growing Healthcare Facilities as a Key Market Driver
The increasing number of healthcare settings worldwide is a significant factor fueling the demand for hospital-acquired infections testing kits. Healthcare environments encompass a broad range of facilities such as acute care hospitals, urgent care centers, rehabilitation clinics, nursing homes, and long-term care facilities, all of which require effective infection control measures. These testing kits are crucial for detecting and managing nosocomial infections, thereby enhancing patient safety across healthcare institutions. For example, in May 2023, the American Hospital Association reported a remarkable increase in the total number of hospitals in the U.S., rising from 6,093 in 2022 to 60,129 in 2023. Additionally, community hospital admissions grew from 31,393,318 in 2022 to 31,967,073 in 2023. Such expansion in healthcare infrastructure directly supports market growth for infection testing kits.

View the full hospital acquired infections testing kits market report:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Impact of Rising Surgical Procedures on the Hospital Acquired Infections Testing Kits Market
An upsurge in surgical procedures is another critical driver for the hospital-acquired infections testing kits market. Surgeries involve incisions or tissue manipulations performed under anesthesia or sedation, which inherently increase the risk of infections by creating entry points for pathogens. The growing elderly population, who often require more medical interventions for chronic and age-related conditions, is contributing to the rise in surgical procedures worldwide. This, in turn, increases the demand for diagnostic tools that can help detect and monitor infections efficiently. For instance, data from the Australian Institute of Health and Welfare showed hospitalizations involving surgery increased from 3.0 million cases in 2022-23 to 3.1 million cases in 2023-24, marking a rise of 100,000 cases. This trend highlights the expanding need for hospital-acquired infection testing kits to support post-surgical patient care.

Regional Insights Highlighting Market Trends in Hospital Acquired Infections Testing Kits
In 2025, North America held the largest share of the hospital-acquired infections testing kits market, reflecting its advanced healthcare infrastructure and high adoption of diagnostic technologies. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by increasing healthcare investments, improving diagnostic capabilities, and rising awareness about infection control. The market report covers a broad geographic scope, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive perspective on global developments in this sector.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X